Hologic, Inc., based in Marlborough, Massachusetts, is a global leader in medical technologies focused on women’s health. The company offers diagnostic, imaging, and surgical products for early detection and treatment. With a market capitalization of $14.75 billion, Hologic is considered a large-cap stock. Despite recent fluctuations, the stock is up 27.8% from its 52-week low in May 2025. Hologic reported third-quarter earnings that exceeded expectations, leading to a 3.7% increase in the stock price over the past three months. The company has made strategic acquisitions to drive growth, with analysts bullish on its future prospects.

Read more at Yahoo Finance: Is Hologic Stock Underperforming the S&P 500?